BridgeMD
New treatment option for Neurodegenerative Disease
Official title Mindfulness Walking Intervention to Enhance Resilience (iWalk)
ClinicalTrials.gov ID: NCT07285954
What this study is testing
- What it's testing
- This study is a randomized controlled trial of the walking meditation intervention (iWalk) program, a multi-component intervention integrating walking meditation, education, and group sessions designed to enhance resilience in individuals with multiple sclerosis (MS). The objectives are to evaluate: 1.
- Time commitment: about 8 weeks
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 110. Healthy volunteers may be eligible.
You may be able to join if
- 18 years or older,
- clinical diagnosis of a neurodegenerative disease such as multiple sclerosis, Alzheimer's disease, Parkinson's disease, stroke, etc.,
- have not practiced meditation regularly (e.g., 10 mins per day) and have never attended any meditation classes or community programs,
- never received meditation training via coaching/certification/life coaching,
- have internet access,
You likely can't join if
- Participants who cannot speak, read, write, or listen in English.
See the full eligibility criteria
- 18 years or older,
- clinical diagnosis of a neurodegenerative disease such as multiple sclerosis, Alzheimer's disease, Parkinson's disease, stroke, etc.,
- have not practiced meditation regularly (e.g., 10 mins per day) and have never attended any meditation classes or community programs,
- never received meditation training via coaching/certification/life coaching,
- have internet access,
- with no severe cognitive impairment, i.e., have a score of ≥ 21 on Modified Telephonic Interview for Cognitive Status (TICS-M),
- be able to walk with or without an assistive device (Patient determined Disease Steps score ranged from 0-6),
- are willing to be assigned by chance to an intervention or a control group,
- are willing to wear Fitbit (a wrist smart watch) for eight weeks,
- are individuals who are right-handed according to the Edinburgh Handedness Questionnaire,
- are willing to participate in all assessments, including in-person testing using electroencephalography (EEG) and cognitive tests, online survey/questionnaires, and online interviews or focus group discussions,
- are willing to wear a Hexoskin t-shirt, which is a heart rate variability monitor, while doing the assessments in person.
- Participants who cannot speak, read, write, or listen in English.
The study team makes the final eligibility decision.
Where it's taking place
- Urbana, Illinois, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The study runs about 8 weeks per participant, based on its public description. The team confirms the exact schedule and number of visits before you enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 110 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Urbana, Illinois, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.